FRNM vs LMRI: stock comparison and AI forecast
Freenome, Inc. (FRNM) and Lumexa Imaging Holdings, Inc. (LMRI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
FRNM Freenome, Inc.
- Market Cap
- $1.25B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
LMRI Lumexa Imaging Holdings, Inc.
- Price
- $11.15 +6.2% · 6M
- Market Cap
- $1.07B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- FRNM is 1.2 times larger than LMRI by market capitalization ($1.25B against $1.07B).
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | FRNM | LMRI |
|---|---|---|
| Market Cap | $1.25B | $1.07B |
| P/B Ratio | – | 1.74x |
| Book Value/Share | – | $6.40 |
Profitability & Margins
| Metric | FRNM | LMRI |
|---|---|---|
| ROA | -1.9% | – |
| ROIC | -5.3% | – |
Financial Health
| Metric | FRNM | LMRI |
|---|---|---|
| Current Ratio | 0.20x | 1.44x |
| D/E Ratio | – | 1.94x |
| Financial Leverage | – | 2.94x |
| Interest Coverage | – | 1.4x |
| Working Capital | -$3M | $78M |
Cash Flow
| Metric | FRNM | LMRI |
|---|---|---|
| Operating Cash Flow | -$910K | – |
Income Statement
| Metric | FRNM | LMRI |
|---|---|---|
| Operating Income | -$4M | – |
| Net Income | -$2M | – |
Dividend & Shareholder Information
| Metric | FRNM | LMRI |
|---|---|---|
| Shares Outstanding | 108M | 96M |
| Net Income Growth | -168.5% | – |
FRNM vs LMRI: stock comparison and AI forecast
Which is bigger, FRNM or LMRI?
FRNM is 1.2 times larger than LMRI by market capitalization ($1.25B against $1.07B).
Which one does Intratio's AI model rank higher, FRNM or LMRI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.